mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-10 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-10 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
3e-10 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-10 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-10 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-10 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
7e-10 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-09 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-09 |